Eric Triau
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 5
-
- S100 Proteins and Annexins 3
- Co-authors
- Koen Van Laere (6 shared papers)Christine Bastin (1 shared paper)Ian Law (4 shared papers)Natalie Nelissen (1 shared paper)Allan W. Andersen (1 shared paper)Éric Salmon (2 shared papers)Alex Kørner (1 shared paper)Guy Bormans (1 shared paper)
- Journals
- Alzheimer s & Dementia (2 papers)Molecular Psychiatry (1 paper)Neurology (1 paper)The Lancet Neurology (1 paper)Annals of Neurology (1 paper)
- Partner nations
- BelgiumUnited KingdomSweden
In The Last Decade
Eric Triau
9 papers receiving 722 citations
Eric Triau's Hit Papers
Peers
Comparison fields: 5 of 79
- Psychiatry and Mental health 386
- Physiology 465
- Cognitive Neuroscience 174
- Neurology 68
- Radiology, Nuclear Medicine and Imaging 189
Countries citing papers authored by Eric Triau
This map shows the geographic impact of Eric Triau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Triau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Triau more than expected).
Fields of papers citing papers by Eric Triau
This network shows the impact of papers produced by Eric Triau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Triau. The network helps show where Eric Triau may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Triau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial Hit paper breakdown → | 2010 | 506 |
| 2 | 2008 | 107 | |
| 3 | 2020 | 68 | |
| 4 | 2022 | 34 | |
| 5 | 1994 | 15 | |
| 6 | Image Acquisition System to Monitor Discomfort in Demented Elderly Patients | 2008 | 3 |
| 7 | 2009 | 2 | |
| 8 | Image Acquisition System to Monitor Discomfort in Demented Elderly Patients | 2007 | 2 |
| 9 | 2009 | 1 | |
| 10 | Primary Outcome Analysis of the Multicentre Phase II Trial of 18F-Flutemetamol, a Pittsburgh Compound B Derivative for In Vivo Beta Amyloid Imaging | 2010 | 0 |
About Eric Triau
Eric Triau is a scholar working on Physiology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Cognitive Neuroscience, having authored 10 papers that have together received 738 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (3 papers), S100 Proteins and Annexins (3 papers), Medical Imaging Techniques and Applications (2 papers), Functional Brain Connectivity Studies (2 papers), Schizophrenia research and treatment (1 paper), Advanced MRI Techniques and Applications (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Psychiatry and Mental health (386 citations), Physiology (465 citations), Cognitive Neuroscience (174 citations), Neurology (68 citations) and Radiology, Nuclear Medicine and Imaging (189 citations). Eric Triau has collaborated with scholars based in Belgium, United Kingdom and Sweden. Frequent co-authors include Koen Van Laere, Christine Bastin, Ian Law, Natalie Nelissen, Allan W. Andersen, Éric Salmon, Alex Kørner, Guy Bormans, Rik Vandenberghe and Christopher Buckley. Their work appears in journals such as Alzheimer s & Dementia, Molecular Psychiatry, Neurology, The Lancet Neurology and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.